Sarepta Therapeutics (SRPT) Net Income Growth (3y) (2013 - 2026)
Sarepta Therapeutics (SRPT) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | 47.10% |
| 10 | Sarepta Therapeutics | 1.72 Bn | 1.31 Bn | 622.04 Mn | 38.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.22% |
| Dec 31, 2025 | -41.93% |
| Sep 30, 2025 | 11.29% |
| Jun 30, 2025 | 41.79% |
| Mar 31, 2025 | -62.12% |
| Dec 31, 2024 | 48.86% |
| Sep 30, 2024 | 39.22% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 30.37% |
| Dec 31, 2023 | 30.85% |
| Sep 30, 2023 | 40.72% |
| Jun 30, 2023 | 45.86% |
| Mar 31, 2023 | -209.13% |
| Dec 31, 2022 | 50.33% |
| Sep 30, 2022 | -26.83% |
| Jun 30, 2022 | 5.74% |
| Mar 31, 2022 | -11.07% |
| Dec 31, 2021 | 4.61% |
| Sep 30, 2021 | 14.26% |
| Jun 30, 2021 | 9.35% |